| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.001 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.0022 | 1 |